Contaminants Compass is a monthly newsletter that provides updates, legal observations and actionable tips to navigate the evolving legal challenges of per- and polyfluoroalkyl substances (PFAS) and similar chemicals and products.
This edition highlights significant litigation and regulatory developments around the country:
- 3M Company’s $7.35 billion aqueous film-forming foam (AFFF) settlement;
- Lululemon’s resolution of a Texas PFAS investigation;
- The Connecticut Water Company’s defense of PFAS class claims;
- EPA’s initiative to advance PFAS destruction research and technology;
- North Carolina’s Water Safety Act and its phased water-sampling requirements; and
- The confidential settlement of National Foam’s AFFF insurance coverage dispute with Zurich.
Look for new editions every month, and feel free to reach out to the McGuireWoods PFAS & Emerging Contaminants Practice Area with questions regarding PFAS issues.
I. 3M Company’s Aqueous Film-Forming Foam Settlement
On Nov. 3, 2026, 3M Company announced that it reached a broad settlement regarding PFAS-related personal injury claims that are the focus of the AFFF Multidistrict Litigation (AFFF MDL). The AFFF MDL is pending in the U.S. District Court for the District of South Carolina.
According to 3M’s press release, “3M will make a pre-tax $7.35 billion nominal commitment over nine years, with a present value of $5.8 billion.” The settlement will address nearly 99% of the current personal injury claims inside and outside of the AFFF MDL. Up to 120,000 plaintiffs will be eligible to participate in the resolution.
3M’s press release emphasized that the settlement agreement is not an admission of liability and that the company is prepared to continue defending itself in PFAS-related litigation. But in its current form, the settlement requires 3M to make phased payments. This includes a $50 million payment from 3M this year, no payments in 2027, and 20% of payments due in the final two years of the nine-year agreement.
While the settlement will resolve most pending claims against 3M stemming from the company’s sale of firefighting foam, 3M still faces PFAS-related litigation elsewhere. Moreover, the settlement is neither final nor approved by the court. The court’s Case Management Order No. 39 (Entry Number 11962) required primary counsel to identify all “Eligible Claimants” by Nov. 13, 2026. In addition, Eligible Claimants without a case before the MDL must file a lawsuit within 10 days thereafter. Case Management Order No. 40 (Entry Number 11964) also provides that “Litigating Plaintiffs” who opt out of the settlement must strictly comply with document-production deadlines or face the dismissal of their claims with prejudice.
II. Lululemon Resolves Texas AG’s PFAS Investigation
As an update to the July 2026 Edition, Lululemon recently reached a settlement with the Texas Attorney General following an investigation into whether the company’s apparel contained PFAS. The deal takes the form of an Assurance of Voluntary Compliance under the Texas Deceptive Trade Practices Act. It was filed on Oct. 19, 2026, in the District Court of Collin County and ends the state’s investigation. The settlement does not contain any admission of wrongdoing or liability and does not contain any penalties.
Texas initiated its investigation of Lululemon after the company allegedly failed to collect and maintain signed restricted substances list (RSL) certificates of acknowledgment from two vendors. Lululemon is a premium athletic apparel company, and as part of its business, it sets RSL thresholds for PFAS in its products and requires vendors to comply with those limits. After reviewing documents provided by Lululemon throughout the course of the investigation, Texas did not identify PFAS in Lululemon’s products or materials.
The Assurance of Voluntary Compliance is not an admission of liability and expressly notes Lululemon’s denial of all alleged noncompliance. But through the filing, Lululemon agreed that it would continue requiring vendors to demonstrate compliance with the company’s RSL. As a result, Texas’ investigation is a good reminder for companies to ensure compliance with their own policies when demonstrating state PFAS compliance. It is also a reminder for companies facing PFAS enforcement to timely respond to complaints and demands and cooperate with state agencies.
III. Connecticut Water Company Alleges PFAS Compliance Defeats Class Claims
In October 2023, several plaintiffs filed a putative class action complaint against the Connecticut Water Company (CWC), alleging that they received water contaminated with detectable levels of PFAS. CWC serves approximately 350,000 people in 60 communities across Connecticut.
According to the second amended complaint filed earlier this year, CWC detected dangerous levels of PFAS chemicals in source bodies of water and wells for years. The complaint also alleges that despite tests demonstrating the presence of PFAS, CWC did not take adequate action to reduce the contamination levels to nondetectable levels. The complaint also lists several “effective methods” to treat and remediate PFAS contamination to nondetectable levels, including activated-carbon treatment, ion-exchange treatment and reverse osmosis (high-pressure membrane) treatment. But according to the complaint, CWC did not use any of those treatment methods.
For those reasons and others, the complaint brings several claims against CWC. These include alleged violations of Connecticut’s product liability act, Conn. Gen. Stat. § 52-572m, et seq., such as strict liability, negligence, failure to warn, and negligent design and manufacture. The complaint also brings claims for alleged violations of Connecticut’s unfair trade practices act, Conn. Gen. Stat. § 42-110a, et seq., and requests statutory punitive damages.
CWC’s answer expressly denies that its water harmed any customers. Moreover, for its Special Defenses, CWC alleges that it publicly reported all PFAS source water testing since at least 2019 and notified customers of PFAS monitoring results — resulting in a “knowing use” and acceptance of potential health risks. CWC also argues that it complied with all applicable regulatory standards. According to CWC, “regardless of any detectable levels of PFAS,” the company’s “compliance with all applicable governmental standards in effect at the time of sale is evidence that the water it supplied was not defective or unreasonably dangerous, that [the company] did not breach any duty of care, that any warnings [the company] provided were adequate, and that [the company] did not act with the reckless disregard required for an award of statutory punitive damages … and bars or limits Plaintiffs’ recovery[.]”
Finally, CWC’s Special Defenses relied on the collective responsibility of third parties for PFAS contamination. According to CWC, PFAS are widely used in a variety of industrial and consumer settings. They are also widely used by upstream polluters over which CWC has no control. As a result, CWC argues that such acts and conditions constitute superseding, intervening or alternative causes of the plaintiffs’ claimed injuries.
Only time will tell whether the court grants class certification. But companies and practitioners alike should pay close attention to CWC’s Special Defenses, particularly its PFAS compliance defense. If the court accepts that defense, the case could serve as a roadmap for companies, utilities and municipalities facing similar lawsuits that allege harm from PFAS contamination.
IV. EPA’s Initiative to Advance PFAS Destruction Research and Technology
On Oct. 26, 2026, EPA Administrator Lee Zeldin announced a new, agency-wide PFAS Technology Evaluation, Coordination, and Harmonization (PFAS TECH) initiative. The effort is intended to accelerate new PFAS treatment and destruction technologies by prioritizing collaboration among EPA, state and federal partners, local governments, and the private sector. According to Zeldin, “[t]echnology innovation is essential to accelerating our efforts to address these contaminants, and EPA’s new PFAS TECH strategy will advance scientific discovery, demonstrate the real-world feasibility of advanced technologies, and help reduce PFAS in the environment.”
EPA’s PFAS TECH initiative has several published goals. First, the initiative seeks to “power innovation in research and development” to advance PFAS treatment and destruction technologies. To do so, EPA pledged to increase funding, leverage public- and private-sector relationships, and support emerging technologies and research. Second, it seeks to “demonstrate what’s possible through pilot-scale initiatives” at Superfund sites, waste and water treatment plants, and drinking water systems. As a result, EPA signaled its intention to conduct and support pilot-scale testing at such sites, across multiple regions, to combat PFAS-related pollution and contamination. Finally, the initiative seeks to “translate progress into practical action.” To reach that goal, EPA intends to create guidance to help stakeholders understand which technologies are best suited to combat the pollution and contamination they face.
Zeldin’s announcement of EPA’s PFAS TECH initiative comes at a critical time. Indeed, stakeholders called on EPA to provide better guidance on EPA’s interim PFAS destruction and disposal guidance, which it released in April 2026. But EPA’s PFAS TECH initiative undoubtedly represents a concerted effort to fast-track PFAS destruction technology and efforts as concerns about PFAS pollution and contamination continue to mount.
V. North Carolina’s Water Safety Act Takes Effect
This past summer, North Carolina Gov. Josh Stein signed a new Water Safety Act into law as part of the state’s 2026 Appropriations Act. Originally designated as Senate Bill 257, the act appears at Session Law 2026-41, section 8.27, pages 220-224. The act authorizes PFAS research funding for the North Carolina Collaboratory at the University of North Carolina at Chapel Hill. Notably, the act also authorizes a two-phase sampling effort intended to identify and quantify measurable PFAS discharges into North Carolina’s surface waters. That sampling will be conducted by the Collaboratory in cooperation with the North Carolina Department of Environmental Quality (DEQ).
According to the act, Phase 1 will target publicly owned treatment works (POTWs) receiving effluent from at least one significant industrial user (SIU), as defined in 40 C.F.R. § 403.3. It will also target every facility holding a National Pollutant Discharge Elimination System (NPDES) permit for direct discharge of process wastewater from an industrial or commercial operation. The Collaboratory and DEQ must complete Phase 1 sampling by Dec. 31, 2027, and submit a report to the General Assembly by March 31, 2028.
Phase 2, on the other hand, targets indirect discharges from every SIU across the state with the same kind of sampling. The Collaboratory and DEQ must complete Phase 2 sampling by Dec. 31, 2028, and submit a second report to the General Assembly by March 31, 2029.
DEQ has already started contacting holders of NPDES industrial discharge permits regarding Phase 1 sampling. DEQ also intends to host an informational webinar for industry personnel this December and has promised to provide further details once its sampling plan is finalized. While no action is required from NPDES industrial discharge permit holders at this time, permit holders should be on the lookout for more guidance and information from DEQ.
The act also authorizes a Biosolids Finding and Study. The Collaboratory will analyze the accumulation of PFAS in biosolids at POTWs, the concentrations of such PFAS, and the final disposition of biosolids generated at and removed by the wastewater facilities. The biosolids study will also consider the development of new management practices and technologies to minimize or remove PFAS. Like the phased water sampling, a biosolids study report must be presented to the General Assembly by Jan. 31, 2029.
Considered in its entirety, the act represents another state effort to combat PFAS contamination and pollution. It also signals an effort to identify the most significant polluters and, in all likelihood, hold such polluters accountable.
VI. Settlement in National Foam and Zurich Resolve AFFF Coverage Dispute
On Oct. 15, 2026, the U.S. District Court for the Northern District of California in National Foam Inc. v. Zurich American Insurance Co., an insurance coverage dispute arising from the AFFF MDL with potentially far-reaching implications for policyholders with PFAS exposures, dismissed the insured’s complaint with prejudice following a confidential settlement.
The resolution follows the court’s significant February 2025 ruling on the scope of the policies’ pollution exclusion. The court declined to read the exclusion as a blanket bar to coverage for all PFAS-related claims against National Foam, a manufacturer of firefighting foam. It concluded that the exclusion’s application turned on the nature of the alleged exposure in each underlying suit. Notably, the ruling rejected an all-or-nothing approach pursuant to an overly broad application of the pollution exclusion that insurers have been advancing to limit their exposure for PFAS claims and opened the door for coverage for some AFFF-related claims.
Central to that ruling was the distinction between direct and indirect exposure claims. Direct exposure claims, such as those brought by firefighters who allege injury from handling or using AFFF products, arise from contact with the product itself rather than from a release of pollutants into the environment. As a result, the pollution exclusion would not apply in some cases. Indirect exposure claims, by contrast, allege injury from PFAS that migrated into soil, groundwater or drinking water and therefore are more likely to be barred based on the “discharge, dispersal or release of pollutants” language in the exclusion. Although the settlement and dismissal foreclose appellate review, the February 2025 ruling remains helpful precedent for manufacturers and insurers evaluating coverage for PFAS claims.